Intracardiac fetal therapy: report of the first successful fetal cardiac intervention in Peru, with postnatal correlation at birth and 18 months of life
Descripción del Articulo
Fetal anemia is a cause of perinatal morbidity and mortality. Although it has differentetiologies and despite the introduction of RhD immunoglobulin prophylaxis,alloimmunization remains one of its main causes. These pregnancies are initiallyidentified by measuring in the fetus the middle cerebral ar...
| Autores: | , , , , , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2024 |
| Institución: | Sociedad Peruana de Obstetricia y Ginecología |
| Repositorio: | Revista Peruana de Ginecología y Obstetricia |
| Lenguaje: | español inglés |
| OAI Identifier: | oai:ginecologiayobstetricia.pe:article/2607 |
| Enlace del recurso: | https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2607 |
| Nivel de acceso: | acceso abierto |
| Materia: | Anemia fetal Rh isoimmunization Fetal heart intervention Blood transfusion intracardiac Anemia fetal Isoinmunización Rh Corazón fetal intervención Transfusión sanguínea intracardiaca |
| id |
REVSPOG_be0d8470410e34dfaecd730729046d58 |
|---|---|
| oai_identifier_str |
oai:ginecologiayobstetricia.pe:article/2607 |
| network_acronym_str |
REVSPOG |
| network_name_str |
Revista Peruana de Ginecología y Obstetricia |
| repository_id_str |
. |
| dc.title.none.fl_str_mv |
Intracardiac fetal therapy: report of the first successful fetal cardiac intervention in Peru, with postnatal correlation at birth and 18 months of life Terapia fetal intracardiaca: comunicación de la primera intervención cardiaca fetal exitosa en el Perú, con correlación posnatal al nacimiento y a los 18 meses de vida |
| title |
Intracardiac fetal therapy: report of the first successful fetal cardiac intervention in Peru, with postnatal correlation at birth and 18 months of life |
| spellingShingle |
Intracardiac fetal therapy: report of the first successful fetal cardiac intervention in Peru, with postnatal correlation at birth and 18 months of life Gil Guevara, Enrique Anemia fetal Rh isoimmunization Fetal heart intervention Blood transfusion intracardiac Anemia fetal Isoinmunización Rh Corazón fetal intervención Transfusión sanguínea intracardiaca |
| title_short |
Intracardiac fetal therapy: report of the first successful fetal cardiac intervention in Peru, with postnatal correlation at birth and 18 months of life |
| title_full |
Intracardiac fetal therapy: report of the first successful fetal cardiac intervention in Peru, with postnatal correlation at birth and 18 months of life |
| title_fullStr |
Intracardiac fetal therapy: report of the first successful fetal cardiac intervention in Peru, with postnatal correlation at birth and 18 months of life |
| title_full_unstemmed |
Intracardiac fetal therapy: report of the first successful fetal cardiac intervention in Peru, with postnatal correlation at birth and 18 months of life |
| title_sort |
Intracardiac fetal therapy: report of the first successful fetal cardiac intervention in Peru, with postnatal correlation at birth and 18 months of life |
| dc.creator.none.fl_str_mv |
Gil Guevara, Enrique Diez Chang, Guillermo Miranda Frisancho, Braowell Pérez, Ina Bazán, Carlos Muñoz Acosta, Jairo Gonzales Carrillo, Oswaldo |
| author |
Gil Guevara, Enrique |
| author_facet |
Gil Guevara, Enrique Diez Chang, Guillermo Miranda Frisancho, Braowell Pérez, Ina Bazán, Carlos Muñoz Acosta, Jairo Gonzales Carrillo, Oswaldo |
| author_role |
author |
| author2 |
Diez Chang, Guillermo Miranda Frisancho, Braowell Pérez, Ina Bazán, Carlos Muñoz Acosta, Jairo Gonzales Carrillo, Oswaldo |
| author2_role |
author author author author author author |
| dc.subject.none.fl_str_mv |
Anemia fetal Rh isoimmunization Fetal heart intervention Blood transfusion intracardiac Anemia fetal Isoinmunización Rh Corazón fetal intervención Transfusión sanguínea intracardiaca |
| topic |
Anemia fetal Rh isoimmunization Fetal heart intervention Blood transfusion intracardiac Anemia fetal Isoinmunización Rh Corazón fetal intervención Transfusión sanguínea intracardiaca |
| description |
Fetal anemia is a cause of perinatal morbidity and mortality. Although it has differentetiologies and despite the introduction of RhD immunoglobulin prophylaxis,alloimmunization remains one of its main causes. These pregnancies are initiallyidentified by measuring in the fetus the middle cerebral artery peak systolic velocity(MCA-PSV) and moderate to severe anemia should be suspected when the MCA-PSVis ≥1.50 multiples of the median. In these cases, the actual hematocrit is determinedby obtaining fetal blood. Intervention with a fetal hemoglobin no lower than 7g/dL results in a better fetal outcome compared to waiting until the development ofsevere anemia <5g/dL or hydrops. Intravascular fetal transfusion is preferable tointraperitoneal transfusion due to higher survival rates, particularly of hydropicfetuses. The umbilical vein is the preferred vascular site due to ease of access andgreater safety compared to other vascular sites. Direct cardiac puncture is rarelyperformed because of an increased risk of serious complications, including fetaldeath. In the present article we present the first case reported in our country ofintracardiac transfusion in a fetus with severe anemia due to Rh isoimmunization,which had an exhaustive and difficult management, but with an excellent subsequentfetal, neonatal and postnatal evolution. |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024-04-03 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2607 10.31403/rpgo.v70i2607 |
| url |
https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2607 |
| identifier_str_mv |
10.31403/rpgo.v70i2607 |
| dc.language.none.fl_str_mv |
spa eng |
| language |
spa eng |
| dc.relation.none.fl_str_mv |
https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2607/2886 https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2607/2887 |
| dc.rights.none.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Sociedad Peruana de Obstetricia y Ginecología |
| publisher.none.fl_str_mv |
Sociedad Peruana de Obstetricia y Ginecología |
| dc.source.none.fl_str_mv |
The Peruvian Journal of Gynecology and Obstetrics ; Vol. 70 No. 1 (2024) Revista Peruana de Ginecología y Obstetricia; Vol. 70 Núm. 1 (2024) 2304-5132 2304-5124 reponame:Revista Peruana de Ginecología y Obstetricia instname:Sociedad Peruana de Obstetricia y Ginecología instacron:SPOG |
| instname_str |
Sociedad Peruana de Obstetricia y Ginecología |
| instacron_str |
SPOG |
| institution |
SPOG |
| reponame_str |
Revista Peruana de Ginecología y Obstetricia |
| collection |
Revista Peruana de Ginecología y Obstetricia |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1868078738547146752 |
| spelling |
Intracardiac fetal therapy: report of the first successful fetal cardiac intervention in Peru, with postnatal correlation at birth and 18 months of lifeTerapia fetal intracardiaca: comunicación de la primera intervención cardiaca fetal exitosa en el Perú, con correlación posnatal al nacimiento y a los 18 meses de vidaGil Guevara, Enrique Diez Chang, Guillermo Miranda Frisancho, Braowell Pérez, Ina Bazán, Carlos Muñoz Acosta, Jairo Gonzales Carrillo, Oswaldo AnemiafetalRh isoimmunizationFetal heart interventionBlood transfusionintracardiacAnemia fetalIsoinmunización RhCorazón fetalintervenciónTransfusión sanguíneaintracardiacaFetal anemia is a cause of perinatal morbidity and mortality. Although it has differentetiologies and despite the introduction of RhD immunoglobulin prophylaxis,alloimmunization remains one of its main causes. These pregnancies are initiallyidentified by measuring in the fetus the middle cerebral artery peak systolic velocity(MCA-PSV) and moderate to severe anemia should be suspected when the MCA-PSVis ≥1.50 multiples of the median. In these cases, the actual hematocrit is determinedby obtaining fetal blood. Intervention with a fetal hemoglobin no lower than 7g/dL results in a better fetal outcome compared to waiting until the development ofsevere anemia <5g/dL or hydrops. Intravascular fetal transfusion is preferable tointraperitoneal transfusion due to higher survival rates, particularly of hydropicfetuses. The umbilical vein is the preferred vascular site due to ease of access andgreater safety compared to other vascular sites. Direct cardiac puncture is rarelyperformed because of an increased risk of serious complications, including fetaldeath. In the present article we present the first case reported in our country ofintracardiac transfusion in a fetus with severe anemia due to Rh isoimmunization,which had an exhaustive and difficult management, but with an excellent subsequentfetal, neonatal and postnatal evolution.La anemia fetal es una causa de morbilidad y mortalidad perinatal. Aunque tienediferentes etiologías y a pesar de la introducción de la profilaxis de inmunoglobulinaRhD, la aloinmunización sigue siendo una de sus principales causas. Estos embarazosse identifican inicialmente midiendo en el feto la velocidad sistólica máxima de laarteria cerebral media (MCA-PSV) y se debe sospechar de anemia moderada a gravecuando el MCA-PSV es ≥1,50 múltiplos de la mediana. En estos casos, el hematocritoreal se determina obteniendo sangre fetal. La intervención con una hemoglobinafetal no menor a 7 g/dL resulta en un mejor resultado fetal en comparación aesperar hasta el desarrollo de anemia grave < a 5 g/dL o hidrops. La transfusiónfetal intravascular es preferible a la transfusión intraperitoneal debido a mayorestasas de supervivencia, particularmente de fetos hidrópicos. La vena umbilical esel sitio vascular preferido debido a la facilidad de acceso y una mayor seguridaden comparación con otros sitios vasculares. La punción cardíaca directa rara vez serealiza debido a un mayor riesgo de complicaciones graves, incluida la muerte fetal.En el presente artículo presentamos el primer caso comunicado en nuestro mediode transfusión intracardiaca en un feto con anemia severa por isoinmunización Rh,el cual tuvo un manejo exhaustivo y difícil, pero con una excelente evolución fetal,neonatal y posnatal.Sociedad Peruana de Obstetricia y Ginecología2024-04-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://ginecologiayobstetricia.pe/index.php/RPGO/article/view/260710.31403/rpgo.v70i2607The Peruvian Journal of Gynecology and Obstetrics ; Vol. 70 No. 1 (2024)Revista Peruana de Ginecología y Obstetricia; Vol. 70 Núm. 1 (2024)2304-51322304-5124reponame:Revista Peruana de Ginecología y Obstetriciainstname:Sociedad Peruana de Obstetricia y Ginecologíainstacron:SPOGspaenghttps://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2607/2886https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2607/2887Derechos de autor 2024 Enrique Gil Guevara, Guillermo Diez Chang, Braowell Miranda Frisancho, Ina Pérez, Carlos Bazán, Jairo Muñoz Acosta, Oswaldo Gonzales Carrillohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:ginecologiayobstetricia.pe:article/26072026-01-12T15:19:13Z |
| score |
13.408945 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).